BCL2 and breast cancer: It has been reported that tamoxifen can induce apoptosis in a time- and dose-dependent manner by modulating Bcl-2 levels in MCF-7 breast cancer cells, which are characterized by overexpression of human epidermal growth factor receptor 2 [49].